Animal- and Plant-Derived Protein Nanocarriers for the Delivery of Natural Compounds in Breast Cancer Chemoprevention
Molecules · 07.07.2026 · 31 (13) · 2391
DOI: 10.3390/molecules31132391 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 07.07.2026. Verfasst von Zuzanna Senkowska und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, 92-215 Lodz, Poland. Hauptthemen laut MEDLINE: Breast Neoplasms, Drug Carriers, Nanoparticles, Biological Products. Die Arbeit nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lodz, Poland.
Abstract (Originalsprache)
Breast cancer remains one of the leading causes of cancer-related mortality among women worldwide, highlighting the need for safer and more effective chemopreventive strategies. Although many phytochemicals can modulate key molecular processes involved in breast carcinogenesis, their chemopreventive potential largely depends on delivery strategies that preserve their biological activity and enable efficient accumulation at the target site. Protein-based nanocarriers have emerged as promising delivery systems capable of improving the protection, solubility, cellular uptake, targeted delivery, and controlled release of bioactive compounds in tumor tissues. This review summarizes recent advances in selected animal- and plant-derived protein nanocarriers used for the encapsulation and delivery of natural compounds in breast cancer chemoprevention. Particular attention is given to their physicochemical properties, encapsulation performance, release behavior, biological activity, targeting potential, and translational limitations. Furthermore, the mechanisms underlying the enhanced anticancer activity of encapsulated phytochemicals, including improved stability, receptor-mediated uptake, pH-responsive release, apoptosis induction, oxidative stress modulation, and inhibition of tumor growth and metastasis, are highlighted. Current challenges, including enzymatic degradation, formulation instability, immunogenicity concerns, manufacturing scalability, and limited clinical evidence, remain important barriers to translation. Overall, selected protein-based nanocarriers represent promising multifunctional platforms for improving the chemopreventive potential of natural compounds in breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, 92-215 Lodz, Poland.
- Department of Medical Biology, Faculty of Pharmacy, Medical University of Lodz, 90-151 Lodz, Poland.
ORCID-Profile: Zuzanna Senkowska, Julia Wojtkowicz, Dominik Zakrzewski, Katarzyna Owczarek, Karolina Niewinna, Urszula Lewandowska
Förderung
- Medical University of Lodz, Poland
Zitieren
APA
Senkowska, Z., Wojtkowicz, J., Zakrzewski, D., Owczarek, K., Niewinna, K., & Lewandowska, U. (2026). Animal- and Plant-Derived Protein Nanocarriers for the Delivery of Natural Compounds in Breast Cancer Chemoprevention. Molecules, 31(13), 2391. https://doi.org/10.3390/molecules31132391
Vancouver
Senkowska Z, Wojtkowicz J, Zakrzewski D, Owczarek K, Niewinna K, Lewandowska U. Animal- and Plant-Derived Protein Nanocarriers for the Delivery of Natural Compounds in Breast Cancer Chemoprevention. Molecules. 2026;31(13):2391. doi:10.3390/molecules31132391
BibTeX
@article{Senkowska2026,
author = {Senkowska, Zuzanna and Wojtkowicz, Julia and Zakrzewski, Dominik and Owczarek, Katarzyna and Niewinna, Karolina and Lewandowska, Urszula},
title = {Animal- and Plant-Derived Protein Nanocarriers for the Delivery of Natural Compounds in Breast Cancer Chemoprevention},
journal = {Molecules},
year = {2026},
volume = {31},
number = {13},
pages = {2391},
doi = {10.3390/molecules31132391}
}
EUVIMED